CBD in Spain: what the law permits and where the red line runs

Spain has no single rule regulating "CBD" as a whole, so the question of whether it is legal has no yes-or-no answer: it depends on the type of product, its origin and the use it is intended for. Cannabidiol is not among the substances controlled by the international narcotics conventions, but that does not automatically make every product containing it marketable. The most contested ground is hemp flower, where commercial practice runs well ahead of the written rule.

What CBD is and why it is regulated separately

Cannabidiol (CBD) is one of the many cannabinoids present in Cannabis sativa L. It is treated differently in law from THC because THC is subject to the international narcotics control regime and CBD, as an isolated substance, is not. That difference explains why there are physical shops and online catalogues selling products with CBD without this meaning that cannabis has been decriminalised as a consumer product: they are two separate discussions, and it is best not to mix them. The general position of cannabis in Spanish law is set out in this guide to what the law says and what it does not.

The point that usually causes confusion is that Spain does not regulate CBD in the abstract, but each category of product separately. An oil, a dried flower, a cream and a medicine are not governed by the same body of rules, even if the first three are advertised with the same three letters in the shop window.

The same product can be beyond reproach under one framework and problematic under another. Hence two shops with apparently identical products may receive different administrative treatment depending on how they present and label what they sell.

The THC threshold and why it matters

The THC threshold constantly cited in the sector comes from European agricultural rules: it is the maximum content permitted in hemp varieties listed in the common catalogue that may be grown for industrial purposes, with prior declaration to the competent authority and subject to field controls.

Two frequent misunderstandings gather here. The first is to read that percentage as a universal authorisation: "if it is below the threshold, anything can be sold". It does not work that way, because each category of product has its own marketing rules, and clearing them depends not on THC content but on whether that category is authorised at all. The second misunderstanding is to assume the threshold refers to the finished product; at source it refers to the cultivated plant and the variety, not to what ends up in a package.

That mismatch between an agricultural limit and a retail market with no rules of its own is, to a large extent, the cause of the legal uncertainty the sector has carried for years.

Hemp flower: the most contested point

Authorisation to grow hemp was historically conceived for fibre and seed, not for marketing the dried inflorescence to the public. That is the root of the conflict: the flagship product of many shops is precisely the part of the plant that the agricultural rules do not contemplate as an end destination.

The sector has responded with labelling formulas — "collector's item", "ornamental use", "not fit for human consumption" — that shift responsibility for the use onto the buyer. In administrative practice, those labels do not settle the matter: inspectors and courts assess the real and foreseeable destination of the product, its presentation, the sales format and the context of the establishment. A label does not change the nature of what is being sold.

The consequences seen so far have been mainly administrative: seizure of stock, penalty proceedings for marketing products not authorised for human consumption and, in some cases, temporary closure of the premises. The absence of criminal proceedings does not mean the absence of a penalty.

What recent case law has said

It is worth separating two planes, because the rulings cited in public debate usually belong to one or the other and do not mean the same thing.

On the criminal plane, settled doctrine requires the substance to have real psychoactive capacity for an offence against public health to exist. Where analysis shows a negligible THC content, the courts have been acquitting, because the element that sustains the offence is missing. It is an important criterion, but a limited one: it says what is not a crime, it does not say what may be sold.

On the administrative and consumer plane, an acquittal in the criminal courts does not prevent the administration from imposing a penalty for marketing a product not authorised for the use it is in fact destined to, for improper advertising or for labelling breaches. Many operators discover this double track when the closing of a criminal case sits alongside an open penalty file.

On the European plane, the Court of Justice of the European Union ruled on CBD oil lawfully produced in another Member State and concluded that cannabidiol cannot be equated with a narcotic within the meaning of the international convention, so that banning its marketing conflicts with the free movement of goods unless there is a proportionate public health justification based on evidence. That ruling concerned an oil, not dried flower, and it did not resolve the question of retail sale of inflorescences.

The result is a patchy landscape: rulings vary according to the specific product, the analyses carried out and the province. There is as yet no decision that has fixed a uniform criterion for trade in hemp flower, and that is why any categorical statement — in either direction — should be read with caution. The variation in rules between territories, which also affects other questions in the sector, is explained in the region-by-region analysis.

What a CBD friendly space is

In this directory, "CBD friendly" is a descriptive label used by the association itself, not a legal status or a certification. It indicates that the space works with low-THC hemp products or allows their consumption on the premises, and it serves to narrow a search in the catalogue. Nothing more.

One consequence of that is worth stating plainly: neither the label nor the directory itself turns an association into a therapeutic channel. An association does not dispense treatments, does not replace a healthcare professional and is not a route to obtaining cannabis for medical purposes; that ground belongs exclusively to the pharmaceutical circuit and to medical prescription. Cannasys Maps is an informational directory and takes no part in either route.

Nor does the label change the rules governing cannabis associations: it does not mean the space is open to the public, it does not replace the joining procedure, it does not authorise taking product out of the premises and it carries no promise of access. An association remains an association regardless of the category under which it is found; what exactly that figure means is explained on the page on what a cannabis club is, and the different formats of space in the comparison of types of associative space.

An associative space should also not be confused with a CBD shop. A shop sells to any adult who walks through the door and is governed by commercial and consumer law; an association operates on a closed associative basis with an admission procedure. When premises mix the two or present one as the other, that is one of the signs worth reviewing before joining, gathered in this checklist.

What cannot be sold under any circumstances

Above the grey areas there are lines that admit no interpretation. These are the main ones.

Two clarifications on that last row. There is a prescription medicine containing CBD authorised by the European medicines agency, subject to specific indications and medical supervision: it is a pharmaceutical route governed by medicines law and bearing no relation to shop products or to the associative circuit. And advertising with health claims is subject to a strict regime, so that therapeutic promises on a label or a website are not commercial over-enthusiasm but a punishable breach.

To this is added the obvious: no product of this kind may be sold to minors, and no establishment may use the CBD shop front as a cover for facilitating access to cannabis containing THC. When that happens, it stops being a labelling question and moves into the criminal ground described in the general guide to the legal framework.

Frequently asked questions

Is it legal to buy CBD products in Spain?

It depends on the category. Cosmetics and external-use products that comply with their specific rules are marketed normally; extracts intended for ingestion do not hold the European authorisation that purpose would require, and hemp flower is the most disputed case. The three letters on the packaging say nothing on their own: what counts is the type of product and the use it is intended for.

Why is hemp flower seized if it is below the THC threshold?

Because the threshold belongs to cultivation rules and does not authorise selling the inflorescence to the public as a consumer product. Administrative action rests not on THC content but on the absence of authorisation for that form of marketing, and it can occur even where there are no criminal proceedings at all.

Can a product with CBD produce a positive result in a drug test?

Tests detect THC, not CBD, and some hemp products contain traces of THC. A positive result has its consequences regardless of the product's origin or its label, as set out in the article on cannabis and driving.

Is a cannabis association the same thing as a CBD shop?

No. They are distinct legal figures: a shop is a commercial activity open to the public, and an association rests on a closed associative circuit with an admission procedure. An association appearing in the directory under the CBD friendly category does not become a shop, does not change its conditions of access and is not thereby enabled as a healthcare route.